Conmed Corp (CNMD) Reports In-Line Q2 EPS; Lowers FY14 Outlook

Conmed Corp (NASDAQ: CNMD) reported Q2 EPS of $0.47, in-line with the analyst estimate of $0.47. Revenue for the quarter came in at $188.2 million versus the consensus estimate of $190.62 million.

Conmed Corp sees FY2014 EPS of $1.85-$1.95, versus prior guidance of $1.9-$2 and the consensus of $1.94. Conmed Corp sees FY2014 revenue of $735-745 million, versus prior guidance of $770-780 million and the consensus of $766.27 million.

For earnings history and earnings-related data on Conmed Corp (CNMD) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Corpay agrees to $100M FTC settlement over marketing practices
• Can global equities keep rising? UBS sees these factors driving upside